African swine fever virus serotype-specific proteins are significant protective antigens for African swine fever

G. Burmakina, A. Malogolovkin, E. R. Tulman, L. Zsak, G. Delhon, D. G. Diel, N. M. Shobogorov, Yu P. Morgunov, S. Yu Morgunov, G. F. Kutish, D. Kolbasov, D. L. Rock

Research output: Contribution to journalArticlepeer-review

Abstract

African swine fever (ASF) is an emerging disease threat for the swine industry worldwide. No ASF vaccine is available and progress is hindered by lack of knowledge concerning the extent of ASFV strain diversity and the viral antigens conferring type-specific protective immunity in pigs. Available data from vaccination/challenge experiments in pigs indicate that ASF protective immunity may be haemadsorption inhibition (HAI) serotype-specific. Recently, we have shown that two ASFV proteins, CD2v (EP402R) and C-type lectin (EP153R), are necessary and sufficient for mediating HAI serological specificity (Malogolovkin et al., 2015).. Here, using ASFV inter-serotypic chimeric viruses and vaccination/challenge experiments in pigs, we demonstrate that serotype-specific CD2v and/or C-type lectin proteins are important for protection against homologous ASFV infection. Thus, these viral proteins represent significant protective antigens for ASFV that should be targeted in future vaccine design and development. Additionally, these data support the concept of HAI serotype-specific protective immunity.

Original languageEnglish (US)
Pages (from-to)1670-1675
Number of pages6
JournalJournal of General Virology
Volume97
Issue number7
DOIs
StatePublished - Jul 2016

ASJC Scopus subject areas

  • Virology

Fingerprint Dive into the research topics of 'African swine fever virus serotype-specific proteins are significant protective antigens for African swine fever'. Together they form a unique fingerprint.

Cite this